| 000 | 01020 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514051754.0 | ||
| 264 | 0 | _c20030207 | |
| 008 | 200302s 0 0 eng d | ||
| 022 | _a1352-0504 | ||
| 024 | 7 |
_a10.1046/j.1365-2893.2002.00394.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLayden, J E | |
| 245 | 0 | 0 |
_aAuthors' reply: first-phase parameters in hepatitis C viral kinetics. _h[electronic resource] |
| 260 |
_bJournal of viral hepatitis _cNov 2002 |
||
| 300 |
_a466 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aHepacivirus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xadministration & dosage |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aNeumann, A U | |
| 700 | 1 | _aLayden, T J | |
| 773 | 0 |
_tJournal of viral hepatitis _gvol. 9 _gno. 6 _gp. 466 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2893.2002.00394.x _zAvailable from publisher's website |
| 999 |
_c12238299 _d12238299 |
||